Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder

Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess genetic variation from 7,608 samples in 1,902 autism spectrum disorder (ASD) families, identifying 255,106 de novo mutations....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Science
Prif Awduron: An, Joon-Yong, Lin, Kevin, Zhu, Lingxue, Werling, Donna M., Dong, Shan, Brand, Harrison, Wang, Harold Z., Zhao, Xuefang, Schwartz, Grace B., Collins, Ryan L., Currall, Benjamin B., Dastmalchi, Claudia, Dea, Jeanselle, Duhn, Clif, Gilson, Michael C., Klei, Lambertus, Liang, Lindsay, Markenscoff-Papadimitriou, Eirene, Pochareddy, Sirisha, Ahituv, Nadav, Buxbaum, Joseph D., Coon, Hilary, Daly, Mark J., Kim, Young Shin, Marth, Gabor T., Neale, Benjamin M., Quinlan, Aaron R., Rubenstein, John L., Sestan, Nenad, State, Matthew W., Willsey, A. Jeremy, Talkowski, Michael E., Devlin, Bernie, Roeder, Kathryn, Sanders, Stephan J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6432922/
https://ncbi.nlm.nih.gov/pubmed/30545852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aat6576
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg